Organigram Holdings Inc.

August 28, 2014 08:00 ET

Organigram Completes Initial Harvest and Prepares For First Shipment

MONCTON, NEW BRUNSWICK--(Marketwired - Aug. 28, 2014) - Organigram Holdings Inc. (TSX VENTURE:OGI)(PINKSHEETS:OGRMF) (the "Company") is pleased to announce that is has recently completed its first harvest of product at its Medical Marijuana facility in Moncton, New Brunswick.

Following the harvest, the medical marijuana underwent a specialty drying process followed by a curing process for optimum quality. The Company has sent a 50 gram sample of bulk product to RPC Laboratory to undergo product testing as per Health Canada guidelines.

The Company expects to receive results from the product testing imminently and is currently preparing to package and begin shipment to its first patients.

CEO Denis Arsenault states, "Our Team has been working very hard to cultivate our first crop which was planted on March 30, 2014. It is with great pride that we have been able to produce an organically grown product, which we are certain, will be very well received by our customers. We look forward to continuing to service our clients with a natural alternative for the various ailments medical marijuana can assist."

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company who's wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram's facility is located in Moncton, New Brunswick and the Company is regulated by the Marihuana for Medical Purposes Regulations.

Please visit for more information.

On Behalf of the Board of Directors of Organigram,

Denis Arsenault, President & CEO

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

This news release contains forward-looking information, which involves known and unknown risks, uncertainties and other factors that may cause actual events to differ materially from current expectation. Important factors - including the availability of funds, the results of financing efforts, the results of exploration activities -- that could cause actual results to differ materially from the Company's expectations are disclosed in the Company's documents filed from time to time on SEDAR (see Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. The company disclaims any intention or obligation, except to the extent required by law, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Contact Information

  • Organigram Holdings Inc.
    Brett Allan
    Director of Investor Relations
    (416) 907-4148